Akebia Therapeutics (AKBA) Non-cash Items (2015 - 2019)

Akebia Therapeutics (AKBA) has 5 years of Non-cash Items data on file, last reported at $3.8 million in Q4 2019.

• Non-cash Items for Q4 2019 came in at $3.8 million, up 59.87% year-over-year; the trailing twelve-month figure through Dec 2019 was $3.8 million (up 59.87% YoY), and the FY2019 annual result was $3.8 million, up 59.87% from the prior year.
• Non-cash Items advanced to $3.8 million in Q4 2019 per AKBA's latest filing, from $2.4 million in the prior quarter.
• Over five years, Non-cash Items peaked at $21.9 million in Q4 2017 and troughed at $2.4 million in Q4 2018.
• A 5-year average of $10.3 million and a median of $10.4 million in 2016 frame the typical range for Non-cash Items.
• The sharpest annual moves came in 2017 and 2018: Non-cash Items jumped 110.13% in 2017, then slumped 89.28% in 2018.
• A 5-year view of Non-cash Items shows it stood at $13.1 million in 2015, then retreated by 20.41% to $10.4 million in 2016, then jumped by 110.13% to $21.9 million in 2017, then tumbled by 89.28% to $2.4 million in 2018, then soared by 59.87% to $3.8 million in 2019.
• Business Quant data shows AKBA's Non-cash Items at $3.8 million in Q4 2019, $2.4 million in Q4 2018, and $21.9 million in Q4 2017.